Farmalíder, S.A.
Records under this name other than the patents Farmalíder, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 1 of 1 · Back to Farmalíder, S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,000,047 | Compound inhibiting activation of the enzyme Erk 1/2 to be used in the treatment of neurodegenerative illnesses Lapsed on the fee record Ended Apr 7, 2023 · USPTO record | Lapsed on the fee record | Ended Apr 7, 2023 | USPTO record |